Detalhe da pesquisa
1.
Multicenter phase II study of moderate low-dose radiotherapy in indolent non-Hodgkin lymphoma: CLCG-iNHL-01 protocol.
Future Oncol
; 20(2): 71-81, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38179936
2.
Evidence of cure for extranodal nasal-type natural killer/T-cell lymphoma with current treatment: an analysis of the CLCG database.
Haematologica
; 108(9): 2467-2475, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36951150
3.
Risk stratification and prognostic value of multi-modal MRI-based radiomics for extranodal nasal-type NK/T-cell lymphoma.
BMC Cancer
; 23(1): 88, 2023 Jan 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-36698118
4.
Outcome and risk prediction of early progression in patients with extranodal natural killer/T cell lymphoma from the CLCG study.
Ann Hematol
; 102(9): 2459-2469, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37306711
5.
Prediction of 5-year overall survival of diffuse large B-cell lymphoma on the pola-R-CHP regimen based on 2-year event-free survival and progression-free survival.
Cancer Med
; 2024 Jan 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38180169
6.
Disparities in mortality risk after diagnosis of hematological malignancies in 185 countries: A global data analysis.
Cancer Lett
; : 216793, 2024 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38513800
7.
Dose-Volume Predictors for Radiation Esophagitis in Patients With Breast Cancer Undergoing Hypofractionated Regional Nodal Radiation Therapy.
Int J Radiat Oncol Biol Phys
; 117(1): 186-197, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37001764
8.
Quality assurance in a phase III, multicenter, randomized trial of POstmastectomy radioThErapy in Node posiTive breast cancer with or without Internal mAmmary nodaL irradiation (POTENTIAL): a planning benchmark case.
Radiat Oncol
; 18(1): 194, 2023 Nov 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38031125
9.
Decreased lymphoma-related deaths and improved long-term relative survival with radiotherapy for early-stage diffuse large B-cell lymphoma in the rituximab era.
Radiother Oncol
; 188: 109902, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37678622
10.
Characteristics and prognosis of distant metastasis after primary treatment for early-stage extranodal nasal-type natural killer/T-cell lymphoma from the China Lymphoma Collaborative Group database.
EJHaem
; 4(1): 78-89, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36819187
11.
Correction: All-purpose nanostrategy based on dose deposition enhancement, cell cycle arrest, DNA damage, and ROS production as prostate cancer radiosensitizer for potential clinical translation.
Nanoscale
; 14(17): 6670, 2022 May 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35466988
12.
Variability of Target Volumes and Organs at Risk Delineation in Breast Cancer Radiation Therapy: Quality Assurance Results of the Pretrial Benchmark Case for the POTENTIAL Trial.
Pract Radiat Oncol
; 12(5): 397-408, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36058618
13.
Influence of age on long-term net survival benefit for early-stage MALT lymphomas treated with radiotherapy: A SEER database analysis (2000-2015).
Radiother Oncol
; 173: 179-187, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35667572
14.
Hypofractionated versus conventionally fractionated image-guided volumetric-modulated arc radiotherapy for localized prostate cancer: a phase II randomized trial from China.
Aging (Albany NY)
; 13(5): 6936-6944, 2021 02 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-33653964
15.
All-purpose nanostrategy based on dose deposition enhancement, cell cycle arrest, DNA damage, and ROS production as prostate cancer radiosensitizer for potential clinical translation.
Nanoscale
; 13(34): 14525-14537, 2021 Sep 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34473816
16.
Radiomics of Multiparametric MRI to Predict Biochemical Recurrence of Localized Prostate Cancer After Radiation Therapy.
Front Oncol
; 10: 731, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32477949